DiaMedica Therapeutics Inc. (DMAC) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for DiaMedica Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$9.82
+13.00% today
Market cap
$469M
Overall quality
51/100
Kronos AI 30-day
−28.0%
0 of 8 simulated paths end higher
DiaMedica Therapeutics Inc. (DMAC) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $469M. It trades at $9.82, up 13.00% today. Its overall quality score is 51 out of 100, ranked against the whole US market. 1 analysts' average target of $12.00 implies +22.2% from today's price. Kronos AI's 30-day forecast is −28.0% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $12.00 |
| Low – high | $12.00 – $12.00 |
| Analysts | 1 |
| Upside to average | +22.2% |
Kronos AI 30-day forecast
| Expected close | $6.26 (−28.0%) |
| Likely range | −30.8% … −27.3% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 37 |
| Solvency | 84 |
| Growth | 31 |
| Overall | 51 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.